A carregar...
TRIMODALITY THERAPY FOR STAGE II-III CARCINOMA OF THE ESOPHAGUS: A DOSE-RANGING STUDY OF CONCURRENT CAPECITABINE, DOCETAXEL, AND THORACIC RADIOTHERAPY
PURPOSE: This dose escalation study was performed to determine the recommended phase II dose of oral capecitabine to be delivered concurrently with thoracic radiation therapy and weekly docetaxel in patients with locally advanced esophageal carcinoma. METHODS: Patients with operable stage II or III...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600150/ https://ncbi.nlm.nih.gov/pubmed/23370365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3182829bf3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|